Back to Search
Start Over
Acute liver failure secondary to ABVD use.
Acute liver failure secondary to ABVD use.
- Source :
-
BMJ case reports [BMJ Case Rep] 2018 Jul 30; Vol. 2018. Date of Electronic Publication: 2018 Jul 30. - Publication Year :
- 2018
-
Abstract
- Hodgkin's lymphoma (HL) is a type of cancer originating in the lymph nodes. The preferred therapy for advanced HL is a combination of chemotherapies including doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD). ABVD has been standard therapy for advanced HL. It is generally considered as safe and rarely has been reported to cause acute liver failure. We present a case of 79-year-old woman with HL, who developed acute liver failure secondary to first cycle of ABVD chemotherapy.<br />Competing Interests: Competing interests: None declared.<br /> (© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.)
- Subjects :
- Aged
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Bleomycin administration & dosage
Bleomycin adverse effects
Brentuximab Vedotin
Chemical and Drug Induced Liver Injury complications
Dacarbazine administration & dosage
Dacarbazine adverse effects
Dose-Response Relationship, Drug
Doxorubicin administration & dosage
Doxorubicin adverse effects
Female
Humans
Treatment Outcome
Vinblastine administration & dosage
Vinblastine adverse effects
Antineoplastic Combined Chemotherapy Protocols adverse effects
Chemical and Drug Induced Liver Injury diagnosis
Hodgkin Disease drug therapy
Immunoconjugates therapeutic use
Syncope chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1757-790X
- Volume :
- 2018
- Database :
- MEDLINE
- Journal :
- BMJ case reports
- Publication Type :
- Academic Journal
- Accession number :
- 30061135
- Full Text :
- https://doi.org/10.1136/bcr-2018-225474